Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus-Reference-Cited by-同舟云学术

Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus

Published:2017-01 Issue:1 Volume:10 Page:42-49
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Kereiakes Dean J.,Ellis Stephen G.,Kimura Takeshi,Abizaid Alexandre,Zhao Weiying,Veldhof Susan,Vu Minh-Thien,Zhang Zhen,Onuma Yoshinobu,Chevalier Bernard,Serruys Patrick W.,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry;Ritsinger;Circ Cardiovasc Interv,2015

2. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention;Singh;Circulation,2004

3. Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus;Stone;Circulation,2011

4. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients;Van Belle;J Am Coll Cardiol,2002

5. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus;Moreno;Circulation,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort;Diabetes and Vascular Disease Research;2023-07

2. Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography;Cardiovascular Diabetology;2023-05-24

3. Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents;Journal of Diabetes Research;2021-11-23

4. The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome;Journal of Clinical Medicine;2021-07-18

5. Comparison of Long-Term Safety and Efficacy of Bioresorbable Scaffolds between Patients with and without Diabetes Mellitus;ACTA CARDIOL SIN;2021